Literature DB >> 14635728

Molecular model of the neural dopamine transporter.

Aina Westrheim Ravna1, Ingebrigt Sylte, Svein G Dahl.   

Abstract

The dopamine transporter (DAT) regulates the action of dopamine by reuptake of the neurotransmitter into presynaptic neurons, and is the main molecular target of amphetamines and cocaine. DAT and the Na+/H+ antiporter (NhaA) are secondary transporter proteins that carry small molecules across a cell membrane against a concentration gradient, using ion gradients as energy source. A 3-dimensional projection map of the E. coli NhaA has confirmed a topology of 12 membrane spanning domains, and was previously used to construct a 3-dimensional NhaA model with 12 trans-membrane alpha-helices (TMHs). The NhaA model, and site directed mutagenesis data on DAT, were used to construct a detailed 3-dimensional DAT model using interactive molecular graphics and empiric force field calculations. The model proposes a dopamine transport mechanism involving TMHs 1, 3, 4, 5, 7 and 11. Asp79, Tyr252 and Tyr274 were the primary cocaine binding residues. Binding of cocaine or its analogue, (-)-2beta-carbomethoxy-3beta-(4-fluorophenyl)tropane (CFT), seemed to lock the transporter in an inactive state, and thus inhibit dopamine transport. The present model may be used to design further experimental studies of the molecular structure and mechanisms of DAT and other secondary transporter proteins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14635728     DOI: 10.1023/a:1026116017725

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  69 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons.

Authors:  A Nicholls; K A Sharp; B Honig
Journal:  Proteins       Date:  1991

3.  Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition, and expression.

Authors:  Z Lin; M Itokawa; G R Uhl
Journal:  FASEB J       Date:  2000-04       Impact factor: 5.191

4.  Improved tools for biological sequence comparison.

Authors:  W R Pearson; D J Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

5.  A putative model of the dopamine transporter.

Authors:  O Edvardsen; S G Dahl
Journal:  Brain Res Mol Brain Res       Date:  1994-12

6.  Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter.

Authors:  E L Barker; R D Blakely
Journal:  Mol Pharmacol       Date:  1996-10       Impact factor: 4.436

7.  Species-scanning mutagenesis of the serotonin transporter reveals residues essential in selective, high-affinity recognition of antidepressants.

Authors:  O V Mortensen; A S Kristensen; O Wiborg
Journal:  J Neurochem       Date:  2001-10       Impact factor: 5.372

8.  Mutational analysis of amiloride sensitivity of the NhaA Na+/H+ antiporter from Vibrio parahaemolyticus.

Authors:  T Kuroda; T Shimamoto; T Mizushima; T Tsuchiya
Journal:  J Bacteriol       Date:  1997-12       Impact factor: 3.490

9.  Comparison of the release of [3H]dopamine from isolated corpus striatum by amphetamine, fenfluramine and unlabelled dopamine.

Authors:  N Y Liang; C O Rutledge
Journal:  Biochem Pharmacol       Date:  1982-03-15       Impact factor: 5.858

10.  High affinity recognition of serotonin transporter antagonists defined by species-scanning mutagenesis. An aromatic residue in transmembrane domain I dictates species-selective recognition of citalopram and mazindol.

Authors:  E L Barker; M A Perlman; E M Adkins; W J Houlihan; Z B Pristupa; H B Niznik; R D Blakely
Journal:  J Biol Chem       Date:  1998-07-31       Impact factor: 5.157

View more
  10 in total

Review 1.  Recognition of psychostimulants, antidepressants, and other inhibitors of synaptic neurotransmitter uptake by the plasma membrane monoamine transporters.

Authors:  Christopher K Surratt; Okechukwu T Ukairo; Suneetha Ramanujapuram
Journal:  AAPS J       Date:  2005-10-27       Impact factor: 4.009

Review 2.  Monoamine transporter structure, function, dynamics, and drug discovery: a computational perspective.

Authors:  Sankar Manepalli; Christopher K Surratt; Jeffry D Madura; Tammy L Nolan
Journal:  AAPS J       Date:  2012-08-24       Impact factor: 4.009

3.  Structure and localisation of drug binding sites on neurotransmitter transporters.

Authors:  Aina W Ravna; Ingebrigt Sylte; Svein G Dahl
Journal:  J Mol Model       Date:  2009-02-24       Impact factor: 1.810

4.  The binding sites for cocaine and dopamine in the dopamine transporter overlap.

Authors:  Thijs Beuming; Julie Kniazeff; Marianne L Bergmann; Lei Shi; Luis Gracia; Klaudia Raniszewska; Amy Hauck Newman; Jonathan A Javitch; Harel Weinstein; Ulrik Gether; Claus J Loland
Journal:  Nat Neurosci       Date:  2008-06-22       Impact factor: 24.884

5.  Substrate binding and formation of an occluded state in the leucine transporter.

Authors:  Leyla Celik; Birgit Schiøtt; Emad Tajkhorshid
Journal:  Biophys J       Date:  2007-11-16       Impact factor: 4.033

6.  Different effects of selective dopamine uptake inhibitors, GBR 12909 and WIN 35428, on HIV-1 Tat toxicity in rat fetal midbrain neurons.

Authors:  Michael Y Aksenov; Marina V Aksenova; Janelle M Silvers; Charles F Mactutus; Rosemarie M Booze
Journal:  Neurotoxicology       Date:  2008-06-19       Impact factor: 4.294

7.  How dopamine transporter interacts with dopamine: insights from molecular modeling and simulation.

Authors:  Xiaoqin Huang; Chang-Guo Zhan
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

8.  Docking and scoring with ICM: the benchmarking results and strategies for improvement.

Authors:  Marco A C Neves; Maxim Totrov; Ruben Abagyan
Journal:  J Comput Aided Mol Des       Date:  2012-05-09       Impact factor: 3.686

Review 9.  Monoamine transporters: insights from molecular dynamics simulations.

Authors:  Julie Grouleff; Lucy Kate Ladefoged; Heidi Koldsø; Birgit Schiøtt
Journal:  Front Pharmacol       Date:  2015-10-16       Impact factor: 5.810

10.  Classic Studies on the Interaction of Cocaine and the Dopamine Transporter.

Authors:  Vivek Verma
Journal:  Clin Psychopharmacol Neurosci       Date:  2015-12-31       Impact factor: 2.582

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.